Blueprint Medicines Corporatio...
NasdaqGS:BPMC
$ 91.34
$-1.76 (-1.89%)
$ 91.34
$-1.76 (-1.89%)
End-of-day quote: 04/30/2024

BPMC - Blueprint Medicines Stock Prediction 2025 - 2030

9 years of reliable Blueprint Medicines stock forecast. The Wall Street analysts predict Outperform for BPMC. See at a glance whether NasdaqGS:BPMC will rise in the future.

$0.00
Forecast 2023
$109.13
Forecast 2025
$185.47
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
$0.00
Forecast 2025
$109.13
Forecast 2030
$185.47
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
0.65
Price-to-book Ratio
42.68
Market Cap
5.74B
TEV
5.53 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$85.71

Blueprint Medicines Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Blueprint Medicines Stock Forecast 2023

$100.00

In the last five quarters, Blueprint Medicines’s Price Target has risen from $78.56 to $85.71 - a 9.1% increase. Thridteen analysts predict that Blueprint Medicines’s share price will increase in the coming year, reaching $100.00. This would represent an increase of 16.67%.

9.48%
9.48
Last update: 05/01/2024

Highest Price Target $130.00

Average Price Target $100.00

Lowest Price Target $50.00

Blueprint Medicines Stock Forecast 2025

Stock Prediction for the Price of One Blueprint Medicines Share in Jan 2025.

In Jan 2025 analysts predict a share price of $99.06. An increase of 8.46% compared to today's share price.

Stock Prediction for the Price of One Blueprint Medicines Share in Feb 2025.

In Feb 2025 analysts predict a share price of $99.98. An increase of 9.46% compared to today's share price.

Stock Prediction for the Price of One Blueprint Medicines Share in Mar 2025.

In Mar 2025 analysts predict a share price of $100.89. An increase of 10.46% compared to today's share price.

Stock Prediction for the Price of One Blueprint Medicines Share in Apr 2025.

In Apr 2025 analysts predict a share price of $101.81. An increase of 11.46% compared to today's share price.

Stock Prediction for the Price of One Blueprint Medicines Share in May 2025.

In May 2025 analysts predict a share price of $102.72. An increase of 12.46% compared to today's share price.

Stock Prediction for the Price of One Blueprint Medicines Share in Jun 2025.

In Jun 2025 analysts predict a share price of $103.64. An increase of 13.47% compared to today's share price.

Stock Prediction for the Price of One Blueprint Medicines Share in Jul 2025.

In Jul 2025 analysts predict a share price of $104.56. An increase of 14.47% compared to today's share price.

Stock Prediction for the Price of One Blueprint Medicines Share in Aug 2025.

In Aug 2025 analysts predict a share price of $105.47. An increase of 15.47% compared to today's share price.

Stock Prediction for the Price of One Blueprint Medicines Share in Sep 2025.

In Sep 2025 analysts predict a share price of $106.39. An increase of 16.47% compared to today's share price.

Stock Prediction for the Price of One Blueprint Medicines Share in Oct 2025.

In Oct 2025 analysts predict a share price of $107.30. An increase of 17.47% compared to today's share price.

Stock Prediction for the Price of One Blueprint Medicines Share in Nov 2025.

In Nov 2025 analysts predict a share price of $108.22. An increase of 18.48% compared to today's share price.

Stock Prediction for the Price of One Blueprint Medicines Share in Dec 2025.

In Dec 2025 analysts predict a share price of $109.13. An increase of 19.48% compared to today's share price.

Blueprint Medicines Stock Predictions 2030

Blueprint Medicines Stock Predictions for Jan 2030.

In January 2030 analysts predict a stock price of $168.36. An increase of 84.32% compared to the previous month's estimate.

Blueprint Medicines Stock Predictions for Feb 2030.

In February 2030 analysts predict a stock price of $169.92. An increase of 86.03% compared to the previous month's estimate.

Blueprint Medicines Stock Predictions for Mar 2030.

In March 2030 analysts predict a stock price of $171.47. An increase of 87.73% compared to the previous month's estimate.

Blueprint Medicines Stock Predictions for Apr 2030.

In April 2030 analysts predict a stock price of $173.03. An increase of 89.43% compared to the previous month's estimate.

Blueprint Medicines Stock Predictions for May 2030.

In May 2030 analysts predict a stock price of $174.58. An increase of 91.14% compared to the previous month's estimate.

Blueprint Medicines Stock Predictions for Jun 2030.

In June 2030 analysts predict a stock price of $176.14. An increase of 92.84% compared to the previous month's estimate.

Blueprint Medicines Stock Predictions for Jul 2030.

In July 2030 analysts predict a stock price of $177.69. An increase of 94.54% compared to the previous month's estimate.

Blueprint Medicines Stock Predictions for Aug 2030.

In August 2030 analysts predict a stock price of $179.25. An increase of 96.24% compared to the previous month's estimate.

Blueprint Medicines Stock Predictions for Sep 2030.

In September 2030 analysts predict a stock price of $180.81. An increase of 97.95% compared to the previous month's estimate.

Blueprint Medicines Stock Predictions for Oct 2030.

In October 2030 analysts predict a stock price of $182.36. An increase of 99.65% compared to the previous month's estimate.

Blueprint Medicines Stock Predictions for Nov 2030.

In November 2030 analysts predict a stock price of $183.92. An increase of 101.35% compared to the previous month's estimate.

Blueprint Medicines Stock Predictions for Dec 2030.

In December 2030 analysts predict a stock price of $185.47. An increase of 103.06% compared to the previous month's estimate.

P/E
0.00
Beta
0.65
Price-to-book Ratio
42.68
Market Cap
5.74B
TEV
5.53 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$85.71

Blueprint Medicines Analyst Ratings Frequently Asked Questions

Who are the analysts watching Blueprint Medicines Corporation?

The following analysts have recently covered Blueprint Medicines:

Baird
Barclays
Citigroup Inc
Citigroup Inc. Research
Goldman Sachs
Guggenheim Securities, LLC
H.C. Wainwright & Co.
JMP Securities
Marktfeld
Morgan Stanley
Piper Sandler Companies
Raymond James & Associates
Stifel
Wedbush Securities Inc.
Wells Fargo Securities, LLC
Oppenheimer & Co. Inc.
Leerink Partners LLC
Needham & Company
TD Cowen
CGS International
Baptista Research
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Blueprint Medicines Corporation?

The following sell-side analysts have recently covered Blueprint Medicines:

Lawson, Peter Richard
Lebowitz, David Neil
Frahm, Marc Alan
Richter, Salveen Jaswal
Schmidt, Michael Werner
Fein, Andrew S.
Benjamin, Reni John
Paraskevopoulos, Michail
Ulz, Michael Eric
Raymond, Christopher Joseph
Canino, Bradley Patrick
Berens, Andrew Scott
Nierengarten, David Matthew
Archila, Derek Christian
Biegler, Matthew Cornell
Kusy, Colleen Margaret
Prendergast, Laura Anne
Fadia, Ami
Majumdar, Ishan
(This information refers to the last 90 days.)